You are here

Article info

Article menu
Download PDFPDF
Commentary
Emerging role of miR-21 in non-alcoholic fatty liver disease

Authors

  1. Correspondence to Dr Samira Benhamouche, Univ. Bordeaux, INSERM, U1053, BordeAux Research in Translational Oncology, BaRITOn, Bordeaux F-33076, France; samira.benhamouche{at}inserm.fr
View Full Text

Citation

Benhamouche-Trouillet S, Postic C
Emerging role of miR-21 in non-alcoholic fatty liver disease
Gut 2016;65:1781-1783.

Publication history

  • Received June 17, 2016
  • Revised June 23, 2016
  • Accepted June 26, 2016
  • First published July 19, 2016.
Online issue publication 
December 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/